Literature DB >> 16563017

A comparative study on the application of hierarchical-agglomerative clustering approaches to organize outputs of reiterated docking runs.

Giovanni Bottegoni1, Andrea Cavalli, Maurizio Recanatini.   

Abstract

Reiterated runs of standard docking protocols usually provide a collection of possible binding modes rather than pinpoint a single solution. Usually, this ensemble is then ranked by means of an energy-based scoring function. However, since many degrees of approximation have to be introduced in the computation of the binding free energy, scoring functions cannot always rank the experimental pose among the top scorers. Cluster analysis might help to overcome this limit, provided that data clusterability has been earlier assessed. In this paper, first, we present a modified version of a test earlier developed by Hopkins to assess whether or not docking outputs show the natural tendency to be grouped in clusters. Then, we report the results of a comparative study on the application of different hierarchical-agglomerative cluster rules to partition docking outputs. The rule that was able to best manage the observed data was finally applied to the whole ensemble of poses collected from several docking tools. The combination of the average linkage rule with the cutting function developed by Sutcliffe and co-workers turned out to be an approach that meets all of the criteria required for a robust clustering protocol. Furthermore, a consensus clustering allowed us to identify the pose closest to the experimental one within a statistically significant cluster, whose number was always of few units.

Mesh:

Substances:

Year:  2006        PMID: 16563017     DOI: 10.1021/ci050141q

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  8 in total

1.  Counting clusters using R-NN curves.

Authors:  Rajarshi Guha; Debojyoti Dutta; David J Wild; Ting Chen
Journal:  J Chem Inf Model       Date:  2007-06-30       Impact factor: 4.956

Review 2.  Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling.

Authors:  M Bernetti; A Cavalli; L Mollica
Journal:  Medchemcomm       Date:  2017-01-30       Impact factor: 3.597

Review 3.  Computational polypharmacology: a new paradigm for drug discovery.

Authors:  Rajan Chaudhari; Zhi Tan; Beibei Huang; Shuxing Zhang
Journal:  Expert Opin Drug Discov       Date:  2017-01-23       Impact factor: 6.098

4.  Exploring the potential of protein-based pharmacophore models in ligand pose prediction and ranking.

Authors:  Bingjie Hu; Markus A Lill
Journal:  J Chem Inf Model       Date:  2013-05-13       Impact factor: 4.956

5.  Empirical entropic contributions in computational docking: evaluation in APS reductase complexes.

Authors:  Max W Chang; Richard K Belew; Kate S Carroll; Arthur J Olson; David S Goodsell
Journal:  J Comput Chem       Date:  2008-08       Impact factor: 3.376

6.  The molecular basis for an allosteric inhibition of K+-flux gating in K2P channels.

Authors:  Susanne Rinné; Aytug K Kiper; Kirsty S Vowinkel; David Ramírez; Marcus Schewe; Mauricio Bedoya; Diana Aser; Isabella Gensler; Michael F Netter; Phillip J Stansfeld; Thomas Baukrowitz; Wendy Gonzalez; Niels Decher
Journal:  Elife       Date:  2019-02-26       Impact factor: 8.140

7.  Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine.

Authors:  David Ramírez; Mauricio Bedoya; Aytug K Kiper; Susanne Rinné; Samuel Morales-Navarro; Erix W Hernández-Rodríguez; Francisco V Sepúlveda; Niels Decher; Wendy González
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

8.  Structural Insights into the Substrate Transport Mechanisms in GTR Transporters through Ensemble Docking.

Authors:  Carlos Peña-Varas; Christa Kanstrup; Ariela Vergara-Jaque; Mariela González-Avendaño; Christoph Crocoll; Osman Mirza; Ingo Dreyer; Hussam Nour-Eldin; David Ramírez
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.